The lived reality of Type 1 diabetes: management technology, mental health, quality of life, and family support, grounded in current research.
Newest public articles in this topic cluster.
Highest growth-index pieces and decision-engine promote picks — still evidence-labeled, not medical advice.
Automated insulin delivery (AID) systems are becoming standard care for Type 1 diabetes. Here's what they do, how they compare, and what evidence tells us about their real-world benefits.
New living with t1d research relevant to Type 1 diabetes, summarized with its evidence label.
Insulin pumps automate insulin delivery 24/7 through a small device worn on your body. Understanding how they work can help you decide if this technology might fit your life with Type 1 diabetes.
Scientists are exploring smaller, more flexible antibody fragments called scFv as potential treatments for Type 1 diabetes. These engineered molecules could target the immune system and metabolic problems that drive the disease.
A team at the University of Colorado Boulder is developing algorithms that could help bionic pancreas devices anticipate blood sugar changes rather than simply respond to them. The goal: give people with Type 1 diabetes more freedom and less constant monitoring.
Misdiagnosis of Type 1 diabetes as Type 2 can delay proper care and treatment. Understanding how these conditions differ may help catch Type 1 earlier.
A new review of research shows that women with Type 1 diabetes experience menopause differently—and may face greater symptom severity. Yet support and information remain limited.
A new study shows that personalized digital support—delivered through text messages and targeted information—may help emerging adults navigate the complex shift from pediatric to adult diabetes care. Researchers identified which types of support matter most to different people.
CGMs are powerful tools for understanding blood sugar patterns, but research shows their real strengths and limitations. Here's what the latest evidence tells us about living better with Type 1 diabetes.
Scientists are working to develop insulin you can swallow instead of inject. Recent trials show progress, but real-world use remains on the horizon.
A new study suggests that how you feel day-to-day may align better with your own typical glucose patterns than with standard medical targets. Here's what the research shows about the gap between guidelines and lived experience.
A large study of nearly 70,000 users reveals how Omnipod 5 performs in everyday life—and how personalized settings affect outcomes.
Running out of insulin before your insulin pump is due for a scheduled change can be stressful. Here's what you need to know about staying prepared and managing this common situation.
Beta Bionics has unveiled early designs for Mint, a tubeless insulin pump currently in development. Here's what the company has shared so far about its features and design.
A small Australian study suggests metformin may help pregnant women with Type 1 diabetes achieve better blood sugar control. Researchers say the findings warrant further investigation.
Living with Type 1 diabetes comes with unique emotional challenges—from fear of low blood sugar to stress and burnout. Experts say caring for your mental health is essential to managing the condition well.
A new study finds that getting started on a tubeless insulin pump takes about 13 minutes less than a traditional tubed pump. Nurses say both options work equally well, but the faster setup could reduce barriers to getting on pump therapy.
Insulin pumps deliver medication continuously under the skin using a small computerized device. Here's what you need to know about how they work and how they're managed.
Researchers are studying a stricter glucose target called time in tight range (TITR) to see if it offers benefits beyond current CGM goals. Here's what the evidence shows so far—and what still needs to be answered.
A new clinical trial found that automated insulin delivery systems help pregnant women with Type 1 diabetes spend more time in safe blood sugar ranges. Experts now recommend these technologies as part of comprehensive pregnancy planning.
Researchers tested a new approach to fine-tune insulin pump settings based on individual responses to food. Early results suggest it could help reduce the time spent with high blood sugar after eating.
New research reviews how automated insulin delivery systems perform during pregnancy in people with Type 1 diabetes, highlighting which systems are available and what expectations are realistic.
New research suggests that the way people think about their own thinking—called metacognitive beliefs—may play a specific role in diabetes-related emotional distress. Understanding this connection could open new paths for psychological support.
A five-year study of adults with type 1 diabetes shows that over half of those with early signs of diabetic eye disease experienced improvement when using modern diabetes management tools. Researchers identified specific measures of glucose control linked to better outcomes.
Researchers are testing a new approach to help teenagers with Type 1 diabetes prepare for the shift to adult healthcare. Early results aim to show whether extra support during this critical handoff improves readiness and health outcomes.
A new technology called continuous ketone monitoring may help people with Type 1 diabetes safely use SGLT2 inhibitors, a class of medication that can sometimes cause a serious condition called euglycemic diabetic ketoacidosis.
Researchers tracked how families using advanced insulin pumps experienced remote diabetes care. Most found video consultations convenient and effective for routine follow-up.
Insulin pumps like the OmniPod have expiration dates, and using an expired device can affect your blood sugar management. Here's what you need to know about replacing your pump.
A new study finds that adolescents who develop stronger skills in using online health information and tools tend to practice better diabetes self-care—and that improved self-care is linked to better quality of life.
Researchers analyzed decades of studies comparing newer fast-acting insulins to older human insulin. Here's what the evidence shows for people using multiple daily injections.
A large study of veterans found that continuous glucose monitoring was associated with reduced death rates over several years. The benefit was strongest in older patients and those not using insulin pumps.
Breakthrough technologies and early screening have transformed how we manage and prevent type 1 diabetes. But they only work if everyone can access them.
Researchers found that the Glycemia Risk Index, a measure derived from continuous glucose monitors, may help predict long-term blood sugar outcomes in people using advanced automated insulin pumps.
A large study of nearly 70,000 users reveals how the Omnipod 5 performs in everyday life—and what glucose targets people actually choose.
New research reveals how nutrition and early-life factors build the bacterial communities in our digestive systems during a critical 1,000-day window. What happens in infancy may influence disease risk decades later.
New automated insulin delivery systems use continuous glucose monitoring and smart algorithms to deliver insulin automatically. Real-world data shows these systems help people spend more time in a healthy glucose range.
A new study examined how an advanced hybrid closed-loop insulin pump affected not just blood sugar, but also fear, mood, and thinking in adults over 65 with long-standing Type 1 diabetes.
Continuous glucose monitors generate far more data than older blood tests. Researchers and clinicians are developing new ways to interpret that data—and working to ensure everyone speaks the same language.
Researchers are launching a pilot study to explore whether pregnant people with type 1 diabetes can safely continue using their insulin pumps during labor, rather than switching to IV insulin as is currently standard practice.
A new review of published research suggests that people with Type 1 diabetes may be able to keep using their automated insulin delivery systems during hospitalization, but more evidence is still needed.
New studies compare different approaches to automated insulin delivery and find consistent improvements in blood sugar control—especially for young people switching from manual injections.
A new study examined how common overweight and obesity are among adults with type 1 diabetes, and what factors—from insulin doses to emotional health—may play a role.
Switching to an automated insulin pump requires patience as the system learns your insulin needs. Early experiences can feel unpredictable, but understanding what's happening can help you manage the adjustment period.
A longtime Omnipod user tried a traditional tubed pump for the first time and reflected on what stood out. Here's what the comparison revealed about daily life with each pump type.
A real-world study of a flexible insulin pump system found that most adults using it achieved good blood sugar control and reported improvements in quality of life. However, low blood sugar events remained a concern for some users.
A growing body of research suggests that continuous glucose monitoring (CGM) may help improve pregnancy outcomes for women with gestational diabetes. Here's what current evidence reveals and what questions remain.
A new study shows that women with Type 1 diabetes using automated insulin pumps experience measurable changes in carbohydrate cravings, insulin requirements, and blood sugar control across different phases of their menstrual cycle.
A new roundtable review identifies barriers to getting the right CGM to the right person—and practical steps the NHS could take to improve access and reduce costs.
A new study shows that insulin sensitivity changes throughout the menstrual cycle in people with Type 1 diabetes using automated insulin delivery systems. Understanding these patterns may help with blood sugar management.
A new study suggests that children's ability to plan, organize, and manage tasks—called executive function—may play an important role in how they and their families experience daily life with Type 1 diabetes.
A new study reveals an unexpected connection: teens whose caregivers have very low anxiety levels tend to have higher blood sugar levels. Researchers say this points to how caregiver involvement—not just stress—shapes diabetes management.
A new study finds that tirzepatide, a medication originally developed for type 2 diabetes and weight management, was associated with significant weight loss and reduced insulin needs in people with type 1 diabetes who are overweight or obese. The findings suggest potential benefits, though more research is needed.
A Type 1 diabetic shares her troubleshooting process after experiencing repeated pod failures and discovers an unexpected culprit. Her experience may help others facing similar issues.
Insulin pump management involves practical details—organizing supplies, checking blood sugar, loading cartridges, and finding the right infusion site. Here's what one person's real routine looks like.
A new study of young people with Type 1 diabetes found that those with an evening chronotype—a natural preference for staying up late—had higher blood sugar levels and reported lower quality of life than morning-oriented peers.
A new study of pregnant women with Type 1 diabetes suggests that time in range may be a better predictor of complications than HbA1c alone—and shows that even with good control, larger babies remain common.
A real-world study found that the MiniMed 780G system improved time in tight glycemic range within weeks. These results add to growing evidence that automated insulin delivery can help people achieve better blood sugar control.
New devices and systems are helping people with Type 1 diabetes achieve better blood sugar control and reduce dangerous lows. Here's what the latest research shows.
The FDA-cleared tubeless pump system showed meaningful improvements in time-in-range and A1C levels in clinical trials. Here's what the evidence actually demonstrated.
From a new insulin biosimilar to shifts in insurance coverage, recent developments are reshaping how people with Type 1 diabetes get care. Here's what you need to know.
A new review of research shows that CGM devices can help some young people with Type 2 diabetes manage their condition, but technical challenges and inconsistent results mean they're not a simple solution for everyone.
A new review of autoimmune disease research reveals that Type 1 diabetes shares inflammatory pathways with chronic rhinosinusitis, a condition affecting the sinuses. Understanding this connection may help doctors identify and manage sinus problems in people with Type 1.
A new study looked at whether patch pumps with automated insulin delivery can simplify carbohydrate counting for people with Type 1 diabetes. Here's what real-world use showed.
A year-long study of adults using Medtronic's 670G hybrid closed-loop insulin pump showed improvements in blood sugar control and quality of life—but the system worked best when users trusted it to work automatically.
A large real-world study shows how adjusting your low-glucose alert settings on automated insulin pumps can help you stay in range while keeping hypoglycemia rare. Here's what the data reveals about choosing the right threshold for your needs.
Recent approvals and clinical evidence show automated insulin delivery systems are expanding beyond standard Type 1 diabetes care into pregnancy management and emerging Type 2 diabetes treatment. Here's what the latest research tells us.
A new study shows that the type of insulin delivery system families use—from pens to automated pumps—affects not only blood sugar control but also how much stress parents experience managing their child's diabetes.
A new review of dietary studies shows that several eating approaches—from low-carbohydrate to Mediterranean diets—can help adults with Type 1 diabetes improve blood sugar control and other health markers. But experts say we still need more research on what works best for different people.
A biotechnology company is launching clinical trials of an experimental insulin designed to work more effectively with closed-loop insulin delivery systems. The research is being supported by Breakthrough T1D, a major diabetes research organization.
Research tracking people with Type 1 diabetes who upgraded to an alarm-equipped glucose monitor found meaningful improvements in blood sugar control over two years. Here's what the data revealed.
New real-world data from nearly 70,000 users reveals how the Omnipod 5 automated insulin delivery system performs in everyday life, and what glucose targets work best.
Real-world studies demonstrate that automated insulin delivery systems help young people with Type 1 diabetes spend more time in their target glucose range. Researchers are tracking how these devices perform outside clinical trials.
A new study shows that children and adolescents who switch from daily insulin injections to pump therapy—especially automated systems—see meaningful improvements in their glucose control within the first six months.
A major review of research compared different ways to track blood sugar during pregnancy for women with Type 1 diabetes. Here's what the evidence shows about keeping both mother and baby healthy.
Researchers at McGill University are investigating whether tirzepatide, a medication already used for type 2 diabetes, could help people with type 1 diabetes get better blood sugar control with insulin pump systems.
A case study shows how one person with Type 1 diabetes and insulin resistance improved their blood sugar control by switching insulin formulations while using an automated insulin delivery system.
A study of 138 children in Khartoum reveals how age, diabetes control, and family dynamics shape daily life with Type 1 diabetes—and where children and parents see things differently.
A large study called MeDiPA is investigating whether diet and exercise changes can help people on blood pressure medication achieve their treatment goals. The research focuses on patients whose blood pressure remains high despite taking medication.
A new study shows that a structured insulin protocol can help keep blood sugar stable for women with Type 1 diabetes during induced labor and delivery. Here's what the research found.
Researchers in British Columbia are running a trial of REACHOUT, a mobile app that connects adults with type 1 diabetes to trained peer supporters. The study aims to learn whether this kind of digital peer support can reduce the emotional burden of managing T1D.
Omnipod 5 is an automated insulin delivery system that adjusts your insulin dose based on real-time glucose readings. Here's how it works and what makes it different.
A detailed analysis of continuous glucose data reveals that after eating carbohydrates, insulin only partially controls the resulting blood sugar spike. Understanding this gap may help refine insulin dosing strategies.
New research reveals that while CGMs, pumps, and automated systems improve blood sugar control, the frequent alarms they generate can trigger emotional distress and unhelpful coping behaviors—and the burden varies significantly by device type.
A new study tracked hypoglycemic and hyperglycemic events in people using automated insulin delivery systems, revealing important differences in how long low and high blood sugars actually last.
A new clinical guide outlines how certain GLP-1 receptor agonist medications can be used safely alongside insulin in adults with Type 1 diabetes. Here's what the evidence shows about who might benefit and how to use them responsibly.
A new study shows that spiritual support addresses real emotional struggles many young people and caregivers face with diabetes—and that trained chaplains may be an underutilized resource in diabetes care.
A large study tracked how youth with Type 1 diabetes fared after switching to automated insulin delivery systems. Researchers found that while everyone improved quickly at first, long-term results varied significantly based on how people used the technology and other factors.
A study measuring insulin pump data from young adults aged 18-22 found that taking insulin at mealtimes is linked to better blood sugar control. The research also uncovered a concerning trend: emerging adults are bolusing at meals less often than teenagers do.
Some people are initially diagnosed with Type 2 diabetes when they actually have Type 1. Understanding the differences can help you get the right diagnosis and care plan.
The Omnipod 5, Tandem t:slim X2, and Medtronic 780G each rely on different continuous glucose monitors. Here's what those differences mean for users.
A new study reveals that people with Type 1 diabetes in underserved areas face significant emotional burdens alongside their disease management. Understanding these challenges is the first step toward better support.
A new qualitative study listened to 12 teenagers living with Type 1 diabetes to understand their daily challenges. The findings highlight the psychological, physical, and social struggles that shape their lived experience—and point toward ways healthcare can better support them.
A new study reveals how children and adolescents with Type 1 diabetes experience daily life—and highlights important differences between how kids and parents perceive their wellbeing.
A new study of 166 adults using closed-loop therapy reveals what matters most to them—and how their priorities shift with age. Here's what they say is working.
A new study reveals that pregnant people with type 1 diabetes who have public insurance face significant barriers to using continuous glucose monitors, even though CGMs improve pregnancy outcomes.
A major review reveals that disordered eating affects up to one in three adults with Type 1 diabetes—but the lack of a standard definition means many cases go unrecognized and untreated.
The FDA-approved bionic pancreas uses artificial intelligence to automate insulin dosing with just one simple meal entry per day. For teens like gymnast Mia Campos, it means less time managing diabetes and more time doing what she loves.
A new 8-week study of the twiist AID system in 19 adults with Type 1 diabetes found that participants spent about 70% of their time in target glucose ranges. The system detected potential insulin delivery problems quickly, helping users stay on track with their insulin therapy.
A new case report shows that automated insulin delivery systems can work for people with type 1 diabetes facing additional health challenges, including kidney disease requiring dialysis. Experts say more research is needed to confirm safety and effectiveness in these complex situations.
A large French study tracked adults using two popular automated insulin delivery systems and found that how well someone's blood sugar was controlled before starting the system was the strongest predictor of meeting targets a year later.
A new study reveals that for lower-income youth and youth of color with Type 1 diabetes, having access to insulin pumps and CGM devices is only part of the challenge. Social barriers at school and limited connections to other Type 1 families can make it harder to actually use these tools.
A new study using continuous glucose monitoring data found that insulin analogues helped young people spend a bit more time in their target blood sugar range and experience fewer low blood sugar episodes compared to human insulin.
Researchers at the University of Colorado Boulder are working to improve how artificial pancreas devices manage Type 1 diabetes by adding predictive algorithms that look beyond just current blood sugar numbers.
Closed-loop insulin pumps like the Omnipod 5 can adjust insulin delivery in real time based on continuous glucose monitor data. We break down how this automation actually works in daily life.
A first-time user walks through unboxing the Omnipod 5 tubeless insulin pump system and preparing for that first pod application. Here's what you need to know before you start.
Omnipod 5 is an automated insulin delivery system that works with your Dexcom G6 continuous glucose monitor to help manage blood sugar. Here's what you need to know about how it works and what to expect.
A new study gathered feedback from teenagers and young adults who tested an app designed to support emotional well-being alongside diabetes management. Here's what they said worked—and what could improve.
The Type 1 diabetes community is marking 2025's progress in cell therapy and disease-modifying treatments while rallying support for federal research funding set to expire this month.
A new study shows that teens with type 1 diabetes who experience diabetes distress can still benefit from building resilience and recognizing their strengths. These positive approaches may help improve self-management and quality of life.
Researchers report that a single medication called dupilumab helped a young child with IPEX syndrome—a rare genetic immune disorder—manage severe eczema and improve his quality of life. This case offers insight into treating the allergic side of a complex disease.
A new study reveals how healthcare visits focused only on glucose control can leave young adults feeling overlooked—and paradoxically make diabetes management harder.
A new cost-effectiveness study shows that automated insulin delivery with Omnipod 5 provides health benefits and economic savings compared to multiple daily injections, even when accounting for higher device costs.
From a new insulin option to expanded CGM coverage and device research, the Type 1 diabetes landscape is evolving. Here's what changed this August.
As CGM expands to type 2 diabetes and beyond, a major review examines where the technology helps—and where benefits remain unclear.
Research shows that children with Type 1 diabetes from migrant-background families face steeper challenges in managing their blood sugar, even when using advanced technology. Understanding these barriers may help improve care for vulnerable populations.
A real-world study of the A8 TouchCare Nano system found that children and adolescents achieved better blood sugar control within weeks of starting the device. Researchers saw improvements in key measures and no serious safety concerns over six months.
A major review of research shows that emotional stress related to managing type 1 diabetes is common and linked to real health outcomes. Understanding diabetes distress matters for your whole-person care.
A new study compared how two popular automated insulin delivery systems handled unannounced meals in teenagers with Type 1 diabetes. Both systems kept blood sugar stable, but one showed a slight edge when meals came without warning.
New research supports continuing automated insulin delivery systems throughout pregnancy and delivery for women with type 1 diabetes, rather than switching to older insulin delivery methods. The key is careful planning and meeting specific safety criteria with your healthcare team.
A new government-funded clinic system in West Bengal shows that accessible, structured diabetes care can significantly improve blood sugar control and reduce costs for families, even in resource-limited settings.
A new study following families using the CamAPS FX hybrid closed-loop system found that while blood sugar improvements appear quickly, parents' trust and positive feelings about the technology build gradually—especially after living with it at home for over a year.
A clinical trial found that a psychoeducation program called HARPdoc helped address the cognitive and emotional barriers that make it harder for some adults to recognize and avoid dangerously low blood sugar episodes.
One person shares their initial experience transitioning from the Dexcom G6 to the newer G7 continuous glucose monitor. Here's what stood out in those first moments.
Researchers are launching a clinical trial to see whether a specialized cognitive dissonance-based group intervention can reduce eating disorder risk in young women with Type 1 diabetes. The program will be delivered virtually over six weeks.
A new study of people using advanced insulin pumps found that most still had difficulty reaching target blood sugar levels. Researchers identified one key factor linked to better outcomes.
A new study shows that starting automated insulin delivery shortly after beginning insulin pump therapy can significantly improve blood sugar control. The improvement came without serious safety concerns, though quality of life measures didn't change.
A Type 1 diabetes community member shares her experience with being initially misdiagnosed and the challenges she faced along the way.
A 12-month extension study in France found that adults using the Omnipod 5 automated system sustained improvements in blood sugar control and quality of life. The research adds to evidence that automated insulin delivery remains safe and effective over time.
A new study reveals a surprising gap: teenagers with Type 1 diabetes often feel prepared to transition to adult care, but that confidence doesn't necessarily predict better glycemic outcomes. Understanding this disconnect could help both patients and healthcare teams prepare more effectively.
A new study shows that regular support from a care navigator nearly tripled continuous glucose monitoring use in patients at high risk for dangerous blood sugar episodes. The findings suggest simple human connection can help close gaps in technology access.
A study of young children with Type 1 diabetes found that parents worry differently about hypoglycemia—but these worries don't necessarily predict blood sugar control. Understanding this gap may help families get better support.
Updated diabetes care guidelines now support automated insulin delivery as a preferred option for adults with type 2 diabetes who need multiple insulin injections. Research shows these systems can improve blood sugar control and reduce the burden of manual insulin management.
An international study led by researchers at UC Calgary found that automated insulin delivery technology helps expectant mothers maintain more stable blood sugar levels during pregnancy. The system adjusts insulin in real time, similar to how a healthy pancreas works.
Researchers are mapping the psychological and social factors that affect mental wellbeing in men with type 2 diabetes. Understanding these connections could help improve overall health outcomes.
Researchers have validated a questionnaire designed to help healthcare providers understand how type 1 diabetes affects the emotional, social, and physical well-being of young people. The tool is now available in Swedish.
The Omnipod 5 insulin pump received FDA approval in 2022, offering a tubeless option that works with continuous glucose monitoring. Here's what the approval means for people with Type 1 diabetes.
Youth with type 1 diabetes face higher rates of depression, anxiety, and other mental health conditions that can make diabetes management harder. New research shows that integrating mental health support into diabetes care improves outcomes.
Researchers are developing short, self-guided digital programs to help teens with Type 1 diabetes manage depression and other mental health challenges. These tools could fill gaps in mental health care, especially for families with limited access to traditional therapy.
Latent autoimmune diabetes in adults (LADA) is frequently misdiagnosed as Type 2 diabetes because its slower onset in middle-aged and older adults looks different from Type 1 diabetes in children. Understanding the differences can help you get the right diagnosis sooner.
A new psychological intervention designed specifically for young adults with Type 1 diabetes shows promise in reducing the emotional burden of disease management. The approach combines peer support with evidence-based coping strategies.
A new review of recent research shows that structured discharge planning—the process of preparing patients to leave the hospital—can significantly improve how well people with diabetes manage their condition at home.
A follow-up study of adults with Type 1 diabetes found that stopping semaglutide was linked to changes in glucose control, including a drop in time spent in range and more variable blood sugars.
A small study found that advanced hybrid closed-loop systems—automated insulin delivery devices—improved blood sugar control for incarcerated people with Type 1 diabetes, even in highly restricted environments.
A new study found that both mindfulness training and diabetes education reduced emotional burden in teens with Type 1 diabetes—but through different routes. Connection with peers emerged as powerful in both approaches.
New research shows that adolescents using automated insulin pumps need more insulin during certain phases of their menstrual cycle, with measurable changes in blood sugar control.
A real-world study of adults over 60 using the MiniMed 780G system shows that customized settings—not one-size-fits-all recommendations—help achieve good blood sugar control while managing age-related health concerns.
New technologies like continuous glucose monitors and automated insulin delivery systems are transforming how children and teens manage Type 1 diabetes—but challenges like device fatigue and unequal access remain.
A large study tracked adults with Type 1 diabetes after starting continuous glucose monitoring and found that most people had stable weight while improving their blood sugar control—but a smaller group gained more weight than expected.
Researchers are enrolling over 300 women with Type 1 diabetes to see if an automated insulin pump system called CamAPS FX helps improve blood sugar control and fetal health during pregnancy.
Researchers in Croatia have validated a diabetes-specific survey that helps doctors and families understand how T1D affects children's daily lives and well-being.
A new study found that people with a specific genetic mitochondrial disease show distinct changes in their gut bacteria compared to healthy individuals and those with Type 1 diabetes. Understanding these differences could eventually inform better approaches to managing gastrointestinal symptoms.
A real-world study of 100 people with Type 1 diabetes shows that the Omnipod 5 closed-loop system improved blood sugar levels and held steady over 12 months. Researchers also found hints about how starting blood sugar levels may affect eye disease risk.
A large study of children and teens using the MiniMed 780G automated insulin delivery system found that blood sugar control remained stable over three years, though the way the device was used shifted over time.
A new study from Turkey shows that government reimbursement for continuous glucose monitors dramatically increased their use among young people with Type 1 diabetes. But the impact on blood sugar control was more modest than expected.
A case study shows how an automated insulin pump system, combined with education and mental health support, improved both blood sugar control and emotional well-being in a patient with long-standing diabetes and serious complications.
A new study shows that when young people with Type 1 diabetes experience low blood sugar while using automated insulin delivery systems, they often swing to high blood sugar afterward. Researchers found ways this pattern affects overall glucose control.
A major new analysis reveals that vision loss from diabetes complications is increasing worldwide among working-age adults, with projections showing the trend will continue through 2050.
A major study from Belgium tracking people with Type 1 diabetes over 14 years shows steady improvements in blood sugar management, especially among those using newer insulin and glucose monitoring systems.
A new study tracking children and adolescents in Taiwan shows that advances in insulin, glucose monitoring, and access to testing supplies have helped more young people achieve better blood sugar management since 2000.
A healthcare provider with Type 1 diabetes shares practical insights from her experience with the Omnipod 5 automated insulin delivery system, including what the algorithm handles well and where manual management still matters.
A long-time Type 1 user shares her experience switching to the Omnipod 5 insulin pump, including the technical challenges she faced and how working with support helped her find solutions.
A new review of 23 studies found that gamified apps and websites can help children with Type 1 diabetes improve their self-management and blood sugar control. But experts say more work is needed to understand which approaches work best and last the longest.
As more people with diabetes age, continuous glucose monitors are emerging as a tool to reduce dangerous lows and catch patterns that fingerstick tests miss. But device alone isn't enough—support, education, and access matter just as much.
A study comparing two insulin delivery methods during pregnancy found that women using hybrid closed-loop pumps had babies with slightly higher birthweight and different blood sugar patterns than those using traditional sensor-augmented pumps.
A follow-up study of the BANDIT trial shows that benefits from baricitinib treatment—a drug that temporarily slows beta cell loss—fade after the medication ends, though the pattern differs between adults and children.
A new study shows that Time-in-Range data from continuous glucose monitors remains useful even when you wear your sensor less often—though consistency matters for accuracy.
A study of 78 older adults with type 1 diabetes found that closed-loop insulin systems are safe and effective—challenging the assumption that older people struggle with diabetes technology.
A comprehensive review of studies shows that automated insulin delivery systems help older adults achieve better blood sugar control and lower stress—without increasing low blood sugar episodes.
A new study shows that automated insulin delivery systems significantly improve blood sugar management in people over 65 with Type 1 diabetes, even those with cognitive challenges. The technology also dramatically reduced dangerous low blood sugar events.
A new study found that adults with Type 1 diabetes achieved similar blood sugar control whether they learned to use an advanced insulin pump through virtual or in-person training. Both groups also saw significant reductions in dangerous low blood sugar events.
A major study tracking over 2,200 people with Type 1 diabetes found that automated insulin delivery systems sustained their benefits over two years, with most users staying on the technology and showing improved blood sugar control.
After 20 years with Type 1 diabetes, one person shares what it's like to transition from continuous glucose monitoring alone to adding an insulin pump. Here's what the first three months looked like.
The integration between Dexcom's smallest sensor yet and the tubeless Omnipod 5 pump is now official, allowing continuous glucose data to flow directly to your insulin pump every 5 minutes.
A long-time insulin pump user shares her honest perspective on switching to the OmniPod 5, including what she sees as real benefits and tradeoffs in daily diabetes management.
The Omnipod 5 is a tubeless insulin pump option that appeals to people who want freedom from tubing or feel anxious about traditional pump therapy. Understanding how it works and whether it fits your management style is key to making the right choice.
A major review of CGM studies reveals consistent improvements in blood sugar levels and fewer low blood sugar events for people with Type 1 diabetes. Here's what you need to know about how this technology is changing diabetes management.
A real-world study shows that eliminating prior authorization for insulin pumps and continuous glucose monitors led to faster access and better blood sugar control for people with Type 1 diabetes in an underserved clinic.